Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart for First Phase Insulin Response in Newly Diagnosed Type 2 Diabetes
NCT00254085Phase 4Unknown
- Sponsor
- Gentofte Hospital
- Start
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Gentofte Hospital. Status: unknown.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00254085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254085.